New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
Paweł Kawalec,1 Katarzyna Śladowska,2 Iwona Malinowska-Lipień,3 Tomasz Brzostek,3 Maria Kózka4 1Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland; 2Department of Experimental Hematology, Institute of Zoology an...
Saved in:
Main Authors: | Kawalec P (Author), Śladowska K (Author), Malinowska-Lipień I (Author), Brzostek T (Author), Kózka M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib
by: Kawalec P, et al.
Published: (2017) -
Cutaneous eruption after commencing baricitinib for rheumatoid arthritis
by: Rosemary Akinbisehin, et al.
Published: (2024) -
Nurses' intention to leave their jobs in relation to work environment factors in Polish hospitals: Cross-sectional study
by: Iwona Malinowska-Lipień, et al.
Published: (2023) -
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
by: Schlueter M, et al.
Published: (2019) -
Dual practice of nurses in Poland against the current staff resources
by: Iwona Malinowska-Lipień, et al.
Published: (2021)